Logo-jrip

Indexing Information

Scupos

 

Member of

Follower of





 

Review

1. Sodium-glucose co-transporter 2 inhibitors (SGLT2i); as a preventive factor of kidney failure in patients with type 2 diabetes; a meta-analysis of randomized controlled trials
Dorsa Jahangiri ORCID, Udit Narayan Padhi ORCID, Henu Kumar Verma ORCID, Bhaskar VKS Lakkakula ORCID, Rohollah Valizadeh ORCID, Hamid Nasri* ORCID
J Renal Inj Prev. 2021;10(4): e35. doi: 10.34172/jrip.2021.35
Scopus ID: 85115654690    
Article
PDF
XML
Cited By:
1
2

Meta-analysis

2. The effect of empagliflozin on cardiovascular outcomes in patients with chronic kidney disease; a systematic review and meta-analysis
Majid Foroutan ORCID, Maliheh Yarmohammadi* ORCID
J Renal Inj Prev. 2025;14(2): e32253. doi: 10.34172/jrip.2025.32253
Article
PDF
XML
Cited By:
Meta-analysis

3. Investigating the association between the administration of SGLT-2 inhibitors and the risk of urinary tract infection; a systematic review and meta-analysis
Ramin Haghighi ORCID, Nasim Zaman Samghabadi ORCID, Roya Raeisi Jaski ORCID, Sonia Razmjou ORCID, Alireza Habibzadeh ORCID, Ahmad Maleki Ahmadabadi ORCID, Babak Gholamine ORCID, Mahdi Behi ORCID, Zahra Tavassoli* ORCID
J Renal Inj Prev. 2024;13(1): e32276. doi: 10.34172/jrip.2024.32276
Article
PDF
XML
Cited By:
0
0
Meta-analysis

4. Effect of sodium-glucose transporter 2 inhibitors on the risk of contrast-induced acute kidney injury; a systematic review and meta-analysis
Sam Mirfendereski ORCID, Mahdieh Ahmadnia ORCID, Ali Hasanpour Dehkordi* ORCID
J Renal Inj Prev. 2025;14(3): e38360. doi: 10.34172/jrip.2025.38360
Article
PDF
XML
Cited By: